Ryne Sandberg Shares Details on Prostate Cancer Relapse
Former Chicago Cubs player Ryne Sandberg recently took to social media to share a devastating update regarding his health with his fans. The ex-MLB second baseman first shocked the sporting world in January 2024 when he revealed that he was suffering from metastatic prostate cancer.
HealthDay on MSN26m
Prostate Cancer Incidence, Mortality Rates Mainly Stable, DecreasingIn most countries, prostate cancer incidence and mortality rates decreased or were stable in the most recent five-year period ...
Prostate cancer vaccines, including dendritic and peptide types, offer hope for improved treatments, but face hurdles in ...
A phase 3 prostate cancer trial of Candel’s oncolytic virus has met its primary endpoint, sending the stock up more than 200% ...
By Karen Roman Candel Therapeutics, Inc. (Nasdaq: CADL) said Phase 3 of its prostate cancer candidate CAN-2409 showed an upgrade in disease-free survival in intermediate-to-high-risk patients. “We ...
Montell Jordan is advocating for prostate cancer awareness and emphasizing the importance of early detection, particularly ...
A breakthrough study has identified the genetic risk factors that contribute to increased prostate cancer in African men. The ...
Shares of Candel Therapeutics took flight in premarket trading Wednesday after the clinical-stage biopharmaceutical company said a late-stage study of its CAN-2409 product candidate met its key goal ...
Adoption of active surveillance or watchful waiting has been increasing among patients with intermediate-risk prostate cancer ...
AngioDynamics has obtained an FDA green light for its NanoKnife prostate cancer ablation system, designed to precisely target ...
Candel Therapeutics said on Wednesday its experimental prostate cancer drug met the main goal of a late-stage trial, sending the company's shares up 64% in premarket trading.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback